Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development
Li, W., Xiong, Y., Shang, C., Twu, K. Y., Hang, C. T., Yang, J., … Chang, C.-P. (2013). Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(5), 1738–43.

Brg1 governs a positive feedback circuit in the hair follicle for tissue regeneration and repair.
Xiong, Y., Li, W., Shang, C., Chen, R. M., Han, P., Yang, J., … Chang, C.-P. (2013). Brg1 governs a positive feedback circuit in the hair follicle for tissue regeneration and repair. Developmental Cell, 25(2), 169–81.

Stringent control of NFATc1 nuclear occupancy is critical for maintaining balanced immune response
Pan, M., Winslow, M. M., Keum, J. S., & Crabtree, G. R. (2007). Stringent control of NFATc1 nuclear occupancy is critical for maintaining balanced immune response. GENE THERAPY AND MOLECULAR BIOLOGY, 11B, 171–76.

Activation of NFAT Signaling in Podocytes Causes Glomerulosclerosis
Wang, Y., Jarad, G., Tripathi, P., Pan, M., Cunningham, J., Martin, D. R., … Chen, F. (2010). Activation of NFAT Signaling in Podocytes Causes Glomerulosclerosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 21(10), 1657–66.

Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials.
Kunz, P. L., Balise, R. R., Fehrenbacher, L., Pan, M., Venook, A. P., Fisher, G. A., … Bergsland, E. K. (2016). Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials. Pancreas, 45(10), 1394–1400.

Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib
Wang, S. X. Y., Zhang, B. M., Wakelee, H. A., Koontz, M. Z., Pan, M. G., Diehn, M., … Neal, J. W. (2019). Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib. ANTI-CANCER DRUGS, 30(5), 537–41.

Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma
Pan, M., Trieu, M. K., Sidhu, M., Yu, J., Seto, T., & Ganjoo, K. (2021). Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma. CANCERS, 13(8).

Rapid Response of a BRCA2/TP53/PTEN-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report.
Pan, M., Ganjoo, K., & Karam, A. (2021). Rapid Response of a BRCA2/TP53/PTEN-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report. The Permanente Journal, 25.

Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy.
Zhou, M. Y., Bui, N. Q., Charville, G. W., Ganjoo, K. N., & Pan, M. (2023). Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy. International Journal of Molecular Sciences, 24(11).

Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies.
Pan, M., Jiang, C., Zhang, Z., Achacoso, N., Solorzano-Pinto, A. V., Tse, P., … Habel, L. A. (2023). Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies. Cancers, 15(10).

TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma.
Pan, M., Jiang, C., Zhang, Z., Achacoso, N., Alexeeff, S., Solorzano, A. V., … Habel, L. A. (2023). TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma. JCO Precision Oncology, 7, e2200570.

Impact of a Virtual Multidisciplinary Sarcoma Case Conference on Treatment Plan and Survival in a Large Integrated Healthcare System
Pan, M., Yu, J., Sidhu, M., Seto, T., & Fang, A. (2021). Impact of a Virtual Multidisciplinary Sarcoma Case Conference on Treatment Plan and Survival in a Large Integrated Healthcare System. JCO ONCOLOGY PRACTICE, 17(11), 681-+.

Understanding Teamwork in the Provision of Cancer Care: Highlighting the Role of Trust
Lazzara, E. H., Keebler, J. R., Day, S., DiazGranados, D., Pan, M., King, M. A., & Tu, S.-P. (2016). Understanding Teamwork in the Provision of Cancer Care: Highlighting the Role of Trust. JOURNAL OF ONCOLOGY PRACTICE, 12(11), 1084-+.

TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer
Pan, M., Jiang, C., Tse, P., Achacoso, N., Alexeeff, S., Solorzano, A., … Habel, L. A. (2022). TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer. JOURNAL OF CLINICAL ONCOLOGY, 40(2), 171-+.

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma
Pan, Y., Gao, J., Lin, J., Ma, Y., Hou, Z., Lin, Y., … Huang, H. (2023). High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma. FRONTIERS IN ENDOCRINOLOGY, 14, 1181538.

Germline BRCA1 Deletion as Driver Mutation for Metastatic Urachal Adenocarcinoma in Patient Who Achieved Complete Response to Rucaparib.
Seto, T., Pujare, D., Song, M.-N. N., Lee, J., Huber, R., Sam, D., & Pan, M. (2019). Germline BRCA1 Deletion as Driver Mutation for Metastatic Urachal Adenocarcinoma in Patient Who Achieved Complete Response to Rucaparib. Journal of Oncology Practice, 15(5), 293–295.

WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
Pan, Y., Lu, F., Xiong, P., Pan, M., Zhang, Z., Lin, X., … Huang, H. (2018). WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 37, 167.

Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53
Ding, W., Tong, Y., Zhang, X., Pan, M., & Chen, S. (2016). Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53. SCIENTIFIC REPORTS, 6, 19793.

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
Hsu, H. L., Shu, H. B., Pan, M. G., & Goeddel, D. V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. CELL, 84(2), 299–308.

The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral-inhibitor of apoptosis proteins
Rothe, M., Pan, M. G., Henzel, W. J., Ayres, T. M., & Goeddel, D. V. (1995). The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral-inhibitor of apoptosis proteins. CELL, 83(7), 1243–1252.

Sequence, genomic organization, and chromosome localization of the mouse TRADD gene
Pan, M. G., Xiong, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., & Goeddel, D. V. (1996). Sequence, genomic organization, and chromosome localization of the mouse TRADD gene. JOURNAL OF INFLAMMATION, 46(3), 168–175.

Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1
Pan, Y., Fei, Q., Xiong, P., Yang, J., Zhang, Z., Lin, X., … Huang, H. (2019). Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1. ONCOIMMUNOLOGY, 8(5), e1581529.

Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer
Pan, Y., Lu, F., Fei, Q., Yu, X., Xiong, P., Yu, X., … Huang, H. (2019). Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer. JOURNAL OF HEMATOLOGY & ONCOLOGY, 12(1), 124.

Pain as Initial Presenting Symptom Is Associated With Delay to Seeking Medical Attention, Higher Risk of Relapse, and Shorter Survival in Patients With Early-Stage Extremity or Trunk Synovial Sarcoma.
Seto, T., Merchant, M., Morse, L. J., Fang, A., Song, M.-N. N., Russell, E. A., & Pan, M. (2022). Pain as Initial Presenting Symptom Is Associated With Delay to Seeking Medical Attention, Higher Risk of Relapse, and Shorter Survival in Patients With Early-Stage Extremity or Trunk Synovial Sarcoma. The Permanente Journal, 26(3), 94–102.

Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern California.
Seto, T., Song, M.-N. N., Trieu, M., Yu, J., Sidhu, M., Liu, C.-M. M., … Pan, M. (2019). Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern California. Medical Sciences (Basel, Switzerland), 7(3).

Prevalence of delay to seeking medical attention in patients with synovial sarcoma and association with inferior outcomes.
Seto, T., Song, M., Russell, E., Sam, D., & Pan, M. (2020). Prevalence of delay to seeking medical attention in patients with synovial sarcoma and association with inferior outcomes. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma.
Pan, M., & Merchant, M. (2018). Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma. Medical Sciences (Basel, Switzerland), 6(1).

Association of Inflammatory Markers with Disease Progression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors.
Pan, M., Alavi, M., & Herrinton, L. J. (2018). Association of Inflammatory Markers with Disease Progression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors. The Permanente Journal, 22, 17–149.

Conditional NFAT activation promotes prostate oncogenesis through cell autonomous and non-cell autonomous effects
Manda, K. R., Tripathi, P., Wang, Y., Humphrey, P. A., Pan, M., & Chen, F. (2013). Conditional NFAT activation promotes prostate oncogenesis through cell autonomous and non-cell autonomous effects. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.

CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation
Pan, M., Santamaria, M., & Wollman, D. B. (2007). CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation. NATURE CLINICAL PRACTICE ONCOLOGY, 4(10), 603–607.

Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma.
Levy, M., Lyon, L., Barbero, E., Wong, J., Suga, M., Sam, D., & Pan, M. (2017). Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma. Medical Sciences (Basel, Switzerland), 5(4).

Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer.
Seto, T., Sam, D., & Pan, M. (2019). Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer. Medical Sciences (Basel, Switzerland), 7(2).

DOPAMINERGIC INHIBITION OF DNA-SYNTHESIS IN PITUITARY-TUMOR CELLS IS ASSOCIATED WITH PHOSPHOTYROSINE PHOSPHATASE-ACTIVITY
FLORIO, T., PAN, M. G., NEWMAN, B., HERSHBERGER, R. E., CIVELLI, O., & STORK, P. J. (1992). DOPAMINERGIC INHIBITION OF DNA-SYNTHESIS IN PITUITARY-TUMOR CELLS IS ASSOCIATED WITH PHOSPHOTYROSINE PHOSPHATASE-ACTIVITY. JOURNAL OF BIOLOGICAL CHEMISTRY, 267(34), 24169–24172.

G-PROTEIN ACTIVATION OF A HORMONE-STIMULATED PHOSPHATASE IN HUMAN TUMOR-CELLS
PAN, M. G., FLORIO, T., & STORK, P. J. (1992). G-PROTEIN ACTIVATION OF A HORMONE-STIMULATED PHOSPHATASE IN HUMAN TUMOR-CELLS. SCIENCE, 256(5060), 1215–1217.

cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway
Vossler, M. R., Yao, H., York, R. D., Pan, M. G., Rim, C. S., & Stork, P. J. (1997). cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. CELL, 89(1), 73–82.

Feasibility and Value of Establishing a Community-Based Virtual Multidisciplinary Sarcoma Case Conference.
Pan, M., Seto, T., Yu, J., Sidhu, M., Kim, B., McCormick, C., … Zou, Y. (2020). Feasibility and Value of Establishing a Community-Based Virtual Multidisciplinary Sarcoma Case Conference. JCO Oncology Practice, OP2000110.

Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms
Tripathi, P., Wang, Y., Coussens, M., Manda, K. R., Casey, A. M., Lin, C., … Chen, F. (2014). Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms. ONCOGENE, 33(14), 1840–1849.

The Wnt-1 proto-oncogene regulates MAP kinase activation by multiple growth factors in PC12 cells.
Pan, M. G., Wang, Y. H., Hirsch, D. D., Labudda, K., & Stork, P. J. (1995). The Wnt-1 proto-oncogene regulates MAP kinase activation by multiple growth factors in PC12 cells. Oncogene, 11(10), 2005–12.

Cloning and expression of two structurally distinct receptor-linked protein-tyrosine phosphatases generated by RNA processing from a single gene.
Pan, M. G., Rim, C., Lu, K. P., Florio, T., & Stork, P. J. (1993). Cloning and expression of two structurally distinct receptor-linked protein-tyrosine phosphatases generated by RNA processing from a single gene. The Journal of Biological Chemistry, 268(26), 19284–91.

[Effect of low protein diet, plus essential amino acids on lipid metabolism in patients with chronic renal failure].
Bi, Z. Q., Pan, M. G., & Cheng, B. S. (1991). [Effect of low protein diet, plus essential amino acids on lipid metabolism in patients with chronic renal failure]. Zhonghua Nei Ke Za Zhi, 30(2), 69–72, 124.

Prolonged disease control with pazopanib following radiation of primary tumor for locally advanced and metastatic soft tissue sarcoma.
Pan, M., Yu, J. C., & Sidhu, M. K. (2022). Prolonged disease control with pazopanib following radiation of primary tumor for locally advanced and metastatic soft tissue sarcoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

TP53 gain-of-function mutations and impact on CDKN2A mutation on prognosis of pancreatic ductal adenocarcinoma.
Pan, M., Jiang, C., Zhang, Z., Achacoso, N., Tse, P., Solorzano, A., … Habel, L. A. (2022). TP53 gain-of-function mutations and impact on CDKN2A mutation on prognosis of pancreatic ductal adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Clinical benefit of imatinib in patients with relapsed tenosynovial giant cell tumor/ pigmented villonodular synovitis (TGCT/PVNS).
Yu, J. C., Sidhu, M. K., Fang, A., Morse, L. J., & Pan, M. (2022). Clinical benefit of imatinib in patients with relapsed tenosynovial giant cell tumor/ pigmented villonodular synovitis (TGCT/PVNS). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Differential impact of different TP53 gain-of-function mutations on overall survival of patients with metastatic colorectal cancer: Results from a large integrated healthcare system.
Pan, M., Jiang, C., Tse, P., Chung, E., Solorzano, A., Hu, W., … Thomas, S. P. (2021). Differential impact of different TP53 gain-of-function mutations on overall survival of patients with metastatic colorectal cancer: Results from a large integrated healthcare system. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Association of TP53 mutation with decreased prevalence of MSI-high, RAS and PI3KCA mutations in metastatic colorectal cancer.
Pan, M., Jiang, C., Tse, P., Solorzano-Pinto, A. V., Chung, E., Truong, T.-G., … Thomas, S. P. (2021). Association of TP53 mutation with decreased prevalence of MSI-high, RAS and PI3KCA mutations in metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Implementing a genomic oncology program in an integrated health care network with large scale genomic Next Generation Sequencing (NGS) testing of advanced cancers in a community setting.
Suga, J. M., Thomas, S. P., Thach-Giao Truong, Sundaresan, T. K., Pan, M., Kim, W., … Habel, L. A. (2020). Implementing a genomic oncology program in an integrated health care network with large scale genomic Next Generation Sequencing (NGS) testing of advanced cancers in a community setting. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

The impact of tumor NGS testing on hereditary cancer risk assessment and population management in an integrated community health care system.
Thomas, S. P., Suga, J. M., Thach-Giao Truong, Sundaresan, T. K., Pan, M., Kim, W., … Habel, L. A. (2020). The impact of tumor NGS testing on hereditary cancer risk assessment and population management in an integrated community health care system. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Improving care quality for patients with soft tissue and bone sarcoma by establishing a national virtual tumor board and electronic consultation platform.
Pan, M., Fang, A., Kavanagh, M., Kim, B., Lee, J. D., McCormick, C., … Yu, J. C. (2016). Improving care quality for patients with soft tissue and bone sarcoma by establishing a national virtual tumor board and electronic consultation platform. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Improving detection of Lynch syndrome using a reflex immunohistochemistry algorithm for all patients with newly diagnosed colorectal cancer
Pan, M., Hoodfar, E., Bergoffen, J. A., Fulton, R., Hofmeister, L., Chavez, A., & Li, D. (2012). Improving detection of Lynch syndrome using a reflex immunohistochemistry algorithm for all patients with newly diagnosed colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Impact of early engagement of patients with clinical trial information in a system-based multidisciplinary breast cancer clinic on clinical trial enrollment
Pan, M., Lee, A. T. C., Seaward, S. A., Ilano, A., House, K., Duran, E., … Kavanagh, M. (2012). Impact of early engagement of patients with clinical trial information in a system-based multidisciplinary breast cancer clinic on clinical trial enrollment. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Overexpression of EphA2 gene in invasive human breast cancer and its association with hormone receptor status.
Pan, M. (2005). Overexpression of EphA2 gene in invasive human breast cancer and its association with hormone receptor status. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Brg1, a chromatin remodeling gene, is suppressed in ER-negative breast cancer in human.
Pan, M. (2005). Brg1, a chromatin remodeling gene, is suppressed in ER-negative breast cancer in human. BREAST CANCER RESEARCH AND TREATMENT. SPRINGER.

Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case Report.
Fang, A. S., Morse, L. J., Wustrack, R., Huber, R., & Pan, M. (2020). Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case Report. The Permanente Journal, 25, 1.

Efficacy and Safety Profile of Combining Vandetanib with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
Tian, W., Ding, W., Kim, S., Zheng, L., Zhang, L., Li, X., … Chen, S. (2013). Efficacy and Safety Profile of Combining Vandetanib with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-Analysis. PLOS ONE, 8(7), e67929.

Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth
Zhang, L., Tong, Y., Zhang, X., Pan, M., & Chen, S. (2015). Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth. DRUG DESIGN DEVELOPMENT AND THERAPY, 9, 5851–5861.

Phase II trial of 21-day regimen of irinotecan and carboplatin for chemonaive or relapsed small-cell lung cancer: Long-term survival
Chen, G. Q., Huynh, M., Fehrenbacher, L., Davies, A. M., West, H., Gordon, P., … Lau, D. H. (2008). Phase II trial of 21-day regimen of irinotecan and carboplatin for chemonaive or relapsed small-cell lung cancer: Long-term survival. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.

Efficacy and safety profile of combining agents against epidermal growth factor receptor or vascular endothelium growth factor receptor with gemcitabine-based chemotherapy in patients with advanced pancreatic cancer: A meta-analysis
Tian, W., Ding, W., Kim, S., Xu, X., Pan, M., & Chen, S. (2013). Efficacy and safety profile of combining agents against epidermal growth factor receptor or vascular endothelium growth factor receptor with gemcitabine-based chemotherapy in patients with advanced pancreatic cancer: A meta-analysis. PANCREATOLOGY, 13(4), 415–422.

Sex-Dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma.
Pan, M., Zhou, M. Y., Jiang, C., Zhang, Z., Bui, N. Q., Bien, J., … Ganjoo, K. N. (2023). Sex-Dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.

PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcoma (https://www.nature.com/articles/s44276-023-00029-3)
Pan, M., Zhou, M., Jiang, C., Zhang, Z., Bui, N., Bien, J., … Habel, L. (2024). PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcoma (https://www.nature.com/articles/s44276-023-00029-3). BJC Reports .

Genomic, clinical characteristics, and treatment outcomes of patients with metastatic castration-sensitive prostate cancer with SPOP mutations: Analysis from the Kaiser Permanente Northern California Healthcare System.
Thomas, S. P., Arora, A., Huang, H. X., Jiang, C., Chung, E., Suga, J. M., … Harzstark, A. (2023). Genomic, clinical characteristics, and treatment outcomes of patients with metastatic castration-sensitive prostate cancer with SPOP mutations: Analysis from the Kaiser Permanente Northern California Healthcare System. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Use of histologic and immunologic factors in sarcoma to predict response rates to immunotherapy
Lee, A. Q., Hao, C., Pan, M., Ganjoo, K. N., & Bui, N. (2024). Use of histologic and immunologic factors in sarcoma to predict response rates to immunotherapy. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.